Literature DB >> 35235008

Ion channel long non-coding RNAs in neuropathic pain.

Ricardo Felix1, David Muñoz-Herrera2, Alejandra Corzo-López2, Miriam Fernández-Gallardo3, Margarita Leyva-Leyva4, Ricardo González-Ramírez4, Alejandro Sandoval5.   

Abstract

Neuropathic pain is one of the primary forms of chronic pain and is the consequence of the somatosensory system's direct injury or disease. It is a relevant public health problem that affects about 10% of the world's general population. In neuropathic pain, alteration in neurotransmission occurs at various levels, including the dorsal root ganglia, the spinal cord, and the brain, resulting from the malfunction of diverse molecules such as receptors, ion channels, and elements of specific intracellular signaling pathways. In this context, there have been exciting advances in elucidating neuropathic pain's cellular and molecular mechanisms in the last decade, including the possible role that long non-coding RNAs (lncRNAs) may play, which open up new alternatives for the development of diagnostic and therapeutic strategies for this condition. This review focuses on recent studies associated with the possible relevance of lncRNAs in the development and maintenance of neuropathic pain through their actions on the functional expression of ion channels. Recognizing the changes in the function and spatio-temporal patterns of expression of these membrane proteins is crucial to understanding the control of neuronal excitability in chronic pain syndromes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Ion channels; Neuropathic pain; Stargazin; lncRNA

Mesh:

Substances:

Year:  2022        PMID: 35235008     DOI: 10.1007/s00424-022-02675-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  119 in total

Review 1.  The Role of Voltage-Gated Sodium Channels in Pain Signaling.

Authors:  David L Bennett; Alex J Clark; Jianying Huang; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

Review 2.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Authors:  Julia Beermann; Maria-Teresa Piccoli; Janika Viereck; Thomas Thum
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 3.  Nicotinic receptor function in the mammalian central nervous system.

Authors:  E X Albuquerque; E F Pereira; N G Castro; M Alkondon; S Reinhardt; H Schröder; A Maelicke
Journal:  Ann N Y Acad Sci       Date:  1995-05-10       Impact factor: 5.691

Review 4.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 5.  Etiology and Pharmacology of Neuropathic Pain.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

6.  The alpha(2)delta subunit augments functional expression and modifies the pharmacology of Ca(V)1.3 L-type channels.

Authors:  Arturo Andrade; Alejandro Sandoval; Ricardo González-Ramírez; Diane Lipscombe; Kevin P Campbell; Ricardo Felix
Journal:  Cell Calcium       Date:  2009-09-30       Impact factor: 6.817

7.  The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin.

Authors:  Claudia S Bauer; Manuela Nieto-Rostro; Wahida Rahman; Alexandra Tran-Van-Minh; Laurent Ferron; Leon Douglas; Ivan Kadurin; Yorain Sri Ranjan; Laura Fernandez-Alacid; Neil S Millar; Anthony H Dickenson; Rafael Lujan; Annette C Dolphin
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

Review 8.  Therapeutic Targeting of Long Non-Coding RNAs in Cancer.

Authors:  Gayatri Arun; Sarah D Diermeier; David L Spector
Journal:  Trends Mol Med       Date:  2018-02-12       Impact factor: 15.272

Review 9.  Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain.

Authors:  Alaa Abd-Elsayed; Markus Jackson; Steven L Gu; Kenneth Fiala; Jianguo Gu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 10.  Pregabalin as a Pain Therapeutic: Beyond Calcium Channels.

Authors:  Sascha R A Alles; Stuart M Cain; Terrance P Snutch
Journal:  Front Cell Neurosci       Date:  2020-04-15       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.